Evidence map›Paper›PMID 29125826›Full record

ArticleDisease models & mechanisms2017

Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.

Gavin Tjin, Eric S White, Alen Faiz, Delphine Sicard, Daniel J Tschumperlin, Annabelle Mahar, Eleanor P W Kable, Janette K Burgess

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 97 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 1 synthesis or guideline pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Sildenafil suppresses the activation of hypertrophic scar fibroblasts by promoting the KLF15-mediated inhibition ofThe Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2026
    Article
  10. Mechanobiology and Resolution of Lung Fibrosis.Annual review of physiology · 2026
    Review
  11. Review
  12. Article
  13. The importance of mechanical forces in chronic respiratory diseases.European respiratory review : an official journal of the European Respiratory Society · 2026
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Gavin TjinRespiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Glebe, New South Wales 2037, Australia gtjin@svi.edu.au j.k.burgess@umcg.nl.ORCID 0000-0002-5125-2801
Eric S WhitePulmonary & Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Alen FaizUniversity of Groningen, University Medical Center Groningen, Department of Pulmonary Diseases, Groningen, 9713 GZ, The Netherlands.ORCID 0000-0003-1740-3538
Delphine SicardDepartment of Physiology & Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-6570-3212
Daniel J TschumperlinDepartment of Physiology & Biomedical Engineering, College of Medicine, Mayo Clinic, Rochester, MN 55905, USA.ORCID 0000-0002-5115-9025
Annabelle MaharDepartment of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales 2050, Australia.ORCID 0000-0003-2268-9737
Eleanor P W KableAustralian Centre for Microscopy and Microanalysis, The University of Sydney, Sydney, New South Wales 2006, Australia.ORCID 0000-0002-2741-0793
Janette K BurgessRespiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Glebe, New South Wales 2037, Australia gtjin@svi.edu.au j.k.burgess@umcg.nl.ORCID 0000-0001-9868-9966
The University of Sydney · AUMayo Clinic · USRoyal Prince Alfred Hospital · AUUniversity Medical Center Groningen · NLUniversity of Michigan · US

Funding

Michigan Institute for Clinical and Health Research (MICHR)UL1TR002240 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LUMENG, JULIE C, MASHOUR, GEORGE ALEXANDER · 2017 to 2022
$54.9M
Transforming Translational Science and Education to Benefit Human HealthUL1TR000043 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY · 2012 to 2015
$26.8M
Mechanobiology of Lung FibrosisR01HL092961 · NHLBI · MAYO CLINIC ROCHESTER · PI Daniel J. Tschumperlin · 2009 to 2026
$8.0M
Matrix and Bioreactors for Human Lung RegenerationU01HL111016 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E, WHITE, ERIC S · 2012 to 2016
$3.2M
Targeting matrix stiffness in lung and liver fibrosisR01HL133320 · NHLBI · MAYO CLINIC ROCHESTER · PI SHAH, VIJAY H., TSCHUMPERLIN, DANIEL J. · 2016 to 2019
$2.2M
NCATS NIH HHS UL1 TR000043NCATS NIH HHS UL1 TR002240NHLBI NIH HHS R01 HL092961NHLBI NIH HHS R01 HL133320NHLBI NIH HHS U01 HL111016
6 · The paper itself

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive scarring disease of the lung with few effective therapeutic options. Structural remodelling of the extracellular matrix [i.e. collagen cross-linking mediated by the lysyl oxidase (LO) family of enzymes (LOX, LOXL1-4)] might contribute to disease pathogenesis and represent a therapeutic target. This study aimed to further our understanding of the mechanisms by which LO inhibitors might improve lung fibrosis. Lung tissues from IPF and non-IPF subjects were examined for collagen structure (second harmonic generation imaging) and LO gene (microarray analysis) and protein (immunohistochemistry and western blotting) levels. Functional effects (collagen structure and tissue stiffness using atomic force microscopy) of LO inhibitors on collagen remodelling were examined in two models, collagen hydrogels and decellularized human lung matrices.

Indexed as

Case-Control StudiesCollagen Type IExtracellular MatrixFibrillar CollagensHumansHydrogelsIdiopathic Pulmonary FibrosisLungProtein-Lysine 6-OxidaseTransforming Growth Factor betaCollagen Type IFibrillar CollagensHydrogelsProtein-Lysine 6-OxidaseTransforming Growth Factor betaCollagenExtracellular matrixIdiopathic pulmonary fibrosisLysyl oxidaseSecond harmonic generation

Identifiers

PMID29125826
PMCPMC5719253
OpenAlexW2765981651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.